COVID-19: Publikationen


Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases
SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
Antibody Response Post-COVID-19 Vaccination in Patients With Chronic Myeloid Leukemia With Comparison Between Comirnaty and CoronaVac Vaccine
A Case of Chronic Myelomonocytic Leukemia Unmasked After Receiving J&J COVID-19 Vaccine
Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients.
Impact of Therapy in Patients with Hematologic Malignancies on Seroconversion Rates After SARS-CoV-2 Vaccination.
Vaccination for SARS-CoV-2 in Hematological Patients.
Longer-term response to SARS-CoV-2 vaccine in MPN patients: Role of ruxolitinib and disease severity.
Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia.
SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis.
Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies.
The serological prevalence of SARS-CoV-2 infection in patients with chronic myeloid leukemia is similar to that in the general population.
Between a rock and a hard place: COVID-19 vaccination and patients on rituximab therapy.
Low rate of seroconversion after mRNA anti-SARS-CoV-2 vaccination in patients with hematological malignancies.
BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies.
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
Cellular response to COVID-19 vaccines in hematologic malignancies patients: a new hope for non-responders?
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study.
Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 "Booster" Vaccination - Observational Data from the LLS National Registry
Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Study
Vaccine Efficacy after Rituximab Exposure: First Interim Analysis of Virtue Project on Behalf of West Midlands Research Consortium, UK

Management hämatologisch-onkologischer Patienten

Management of Newly Diagnosed Chronic Myeloid Leukemia During COVID-19 Hospitalization: A Teaching Case
Management of Newly Diagnosed Chronic Myeloid Leukemia During COVID-19 Hospitalization: A Teaching Case
The Venetoclax/Azacitidine Combination Targets the Disease Clone in Acute Myeloid Leukemia, Being Effective and Safe in a Patient with COVID-19
Acute Leukemia diagnosis during the Covid-19 pandemic
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group.
Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
How the COVID-19 Pandemic Reshaped the Management of Leukemia and Affected Patient Outcomes.
Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19.
Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US.
Thrombotic and Clinical Outcomes in Patients with Hematologic Malignancy and COVID-19.
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research.
ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection.
MiR-181a and -b expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation, COVID-19 and torque teno viruses.
Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan.
A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy
The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey.
The Impact of COVID-19 Pandemic on Cancer Care in a Tertiary Care Facility.
Impact of nationwide lockdown on cancer care during COVID-19 pandemic: A retrospective analysis from western India.
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey.
Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries.
High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies.
Personalized at-home autologous hematopoietic stem cell transplantation during the SARS-CoV-2 outbreak.
Challenges of Cellular Therapy During the COVID-19 Pandemic.
Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.
Lessons learned for successful treatment of AML in the second wave of COVID-19 outbreak.
Results of a national UK physician reported survey of COVID-19 infection in patients with a myeloproliferative neoplasm.
The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: Single-centre comparative study between 2019 and 2020 cohorts in Madrid.
Treatment of Acute Leukemia During COVID-19: Focused Review of Evidence.
Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy.
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Impact of the COVID-19 pandemic on clinical trials with drugs
The management of hematologic malignancies during the COVID-19 pandemic.
Characteristics and mechanisms to control a COVID-19 outbreak on a leukemia and stem cell transplantation unit.
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection.
Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
Clinical characteristics and mortality of patients with hematologic malignancies and COVID-19: a systematic review.
Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients
Biomarkers of Pro-Inflammatory Response May Identifiy Cancer Patients at Risk of Adverse Outcomes From SARS-CoV-2 Infection
The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities
The LNT Issue Is About Politics and Economics, Not Safety.
Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience.
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
COVID-19 in cancer patients can be challenging to screen in a resource limited setting.
Cancer inpatients with COVID-19: A report from the Brazilian National Cancer Institute.
COVID-19 and myeloproliferative neoplasms: some considerations
Concurrent Diagnosis of Acute Myeloid Leukemia and COVID-19: A Management Challenge.
Successful management of SARS-CoV-2 acute respiratory distress syndrome and newly diagnosed acute lymphoblastic leukemia
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Guidelines for therapy of patients with chronic myeloproliferative neoplasms during the novel coronavirus SARS-CoV2 pandemic.
Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic.
Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study.
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey.
Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey.
Regional BCG vaccination policy in former East- and West Germany may impact on both severity of SARS-CoV-2 and incidence of childhood leukemia.
Risk factors for death in 1859 subjects with COVID-19.
Rewriting the rules for care of MDS and AML patients in the time of COVID-19
Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic
Frequently Asked Questions Regarding SARS-CoV-2 in Cancer Patients-Recommendations for Clinicians Caring for Patients With Malignant Diseases
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation
Management of hematologic disease under the COVID-19 pandemic: experience from China
ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic
Treating Leukemia in the Time of COVID-19
Risk of COVID-19 for patients with cancer
Managing COVID-19 in the oncology clinic and avoiding the distraction effect
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic
Hematology in the time of COVID-19
Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic
Oncology Practice During the COVID-19 Pandemic
Acute leukemia in the time of COVID-19


Hematopoietic Stem Cell Transplantation to a Patient with Acute Myeloid Leukemia from a Sibling Donor Positive for SARS-CoV-2 by RT-PCR Test
Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19
A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia
Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies a report from the ITA-HEMA-COV
Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality
COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia
Special case of a patient in the blast phase of chronic myeloid leukemia successfully treated with tocilizumab during critical SARS-CoV-2 infection.
Isolated CNS Relapse in 2 High-Risk B-cell Acute Lymphoblastic Leukemia Patients Following SARS-CoV-2 Infection.
Prolonged viral shedding of SARS-CoV-2 in patients with acute leukemia.
Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity.
Safety of SARS-CoV-2 vaccines in patients with chronic myeloid leukemia: a multicenter survey in China.
Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study.
Suspected Drug-induced Liver Injury Due to 6-Mercaptopurine With a Superimposed SARS-CoV-2 Infection in a Patient With B-ALL.
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients - A Czech multicenter experience.
Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review.
COVID-19-Associated Pulmonary Aspergillosis in Patients with Acute Leukemia: A Single-Center Study.
COVID-19 and seasonal influenza: a comparative analysis in patients with hematological malignancies.
Varicella-Zoster virus reactivation following SARS-CoV-2 immunization in two patients with leukemia.
Oral etoposide combined with oral arsenic plus retinoic acid for two cases with newly diagnosed high-risk acute promyelocytic leukemia during COVID19 pandemic.
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution.
Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination.
COVID-19, Acute Lymphoblastic Leukemia, and Down Syndrome: A Short Review and a Case Report.
Complicated pulmonary human coronavirus-NL63 infection after a second allogeneic hematopoietic stem cell transplantation for acute B-lymphocytic leukemia: A case report.
Newly Diagnosed Acute Myeloid Leukemia in a Patient With Severe SARS-CoV-2 Infection.
Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report.
A rare presentation of an elderly patient with acute lymphocytic leukemia and platelet count of zero associated with ST-elevation myocardial infarction, pulmonary thromboembolism in the setting of SARS-CoV 2: a case report.
Cerebral Venous Thrombosis in Acute Lymphoblastic Leukemia with Severe COVID-19: a Case Report.
Key Pathogenic Factors in Coronavirus Disease 2019-Associated Coagulopathy and Acute Lung Injury Highlighted in a Patient With Copresentation of Acute Myelocytic Leukemia: A Case Report.
COVID-19 and adult acute lymphoblastic leukemia: Presentation and management.
Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2.
COVID-19 in a 13-year-old patient with acute lymphoblastic leukemia.
Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency.
Sudden death of a SARS-CoV-2 patient with NPM1 + acute myeloid leukemia mimicking acute promyelocytic leukemia.
Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report.
Acute macular neuroretinopathy in a patient with acute myeloid leukemia and deceased by COVID-19: a case report.
COVID-19 in patients with Acute Leukemia: two cases with different outcomes.
COVID-19 in a patient with chronic myelomonocytic leukemia: a twisting tale.
Transient increase in blast count following COVID-19 infection mimicking acute leukemia.
Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR.
Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients.
Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom
COVID-19 in Chronic-Phase Chronic Myeloid Leukemia Patients: A Single Center Survey from Turkey
Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis.
Treatment of Immunocompromised COVID-19 patients with Convalescent Plasma.
Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran.
Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia.
Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors.
COVID - 19 post Hematopoietic Cell Transplant, a Report of 11 Cases from a Single Center
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.
Clinical characteristics of four cancer patients with SARS-CoV-2 infection in Wuhan, China.
Clinical Characteristics of Hematological Patients Concomitant with COVID-19.
Impact of Covid-19 on the treatment of acute myeloid leukemia.
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
Confirmed Coronavirus Disease-19 (COVID-19) in a Male with Chronic Myeloid Leukemia Complicated by Febrile Neutropenia and Acute Respiratory Distress Syndrome.
Atypical Imaging Findings in Leukemia With SARS-CoV-2 Infection
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a Case Report and Review of ABL Kinase Involvement in Viral Infection
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
COVID-19 in persons with chronic myeloid leukaemia
COVID-19 in persons with haematological cancers
Response to "COVID-19 in persons with haematological cancers"
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality

Behandlung und Mechanismus

COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA)
Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis.
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis.
Effect of SARS-CoV-2 Entry Factors on Myeloid Cancers.
Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study
Acute Respiratory Distress Syndrome in a Patient With Acute Promyelocytic Leukemia: Overlapping Between Differentiation Syndrome and COVID-19.
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis.
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution.
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial.
Proposition of a new allosteric binding site for potential SARS-CoV-2 3CL protease inhibitors by utilizing molecular dynamics simulations and ensemble docking.
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms.
Anti-TNF-alpha agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.
Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.
Impact of chemotherapy on lymphocytes and serological memory in recovered COVID-19 patients with acute leukemia.
Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) without Interruption.
Ruxolitinib withdrawal due to the COVID-19.
Response to: Ruxolitinib withdrawal due to the COVID-19.
Convalescent hyperimmune plasma in patients with hematologic malignancies and severe COVID-19 infections.
Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies.
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
Differential impact of BTK active site inhibitors on the conformational state of full-length BTK
Imatinib is not a potent anti-SARS-CoV-2 drug.
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.
Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia.
Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial.
Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation
Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19
SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
Cancer Patients in SARS-CoV-2 Infection: A Nationwide Analysis in China
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1
Hematological features of persons with COVID-19
Lower Antibodies Rate in Cancer Patients After Symptomatic COVID-19 Than In Healthcare Workers

Pädiatrische Patienten

A 10-Year-Old Girl With Late Acute Lymphoblastic Leukemia Recurrence Diagnosed With COVID-19 and Treated With Remdesivir.
Multisystem Inflammatory Syndrome in Children During Induction Chemotherapy in a Newly Diagnosed Pediatric Acute Myeloid Leukemia and Concurrent COVID-19.
COVID-19-related Gastrointestinal Bleeding in a Pediatric Patient With ALL.
SARS CoV-2 Antibody Persistence During Induction Chemotherapy for Pediatric T-Cell Acute Lymphoblastic Leukemia.
Acute Lymphoblastic Leukemia Diagnosis Following Infection With SARS-CoV-2: Pure Randomness or Reproducible Causation?
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series.
Giant intracardiac thrombosis in an infant with leukaemia and prolonged COVID-19 viral RNA shedding: a case report.
SARS-CoV-2 At diagnosis of acute lymphoblastic leukemia-Case series. To worry about COVID or leukemia? A developing country's perspective.
Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.
Successful ECMO therapy in a child with COVID-19-associated ARDS and acute lymphoblastic leukemia.
COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).
The Status of Pediatric Patients With Hematological Malignancy During COVID-19 Pandemic in Wuhan City, China.
The Impact of COVID-19 Pandemic in Children With Cancer: A Report From Saudi Arabia.
Childhood B-Cell Acute Lymphoblastic Leukemia Following SARS CoV-2 Infection: A Potential Second "Hit" in Leukemogenesis.
Management of an Immunocompromised Pediatric Patient With Multiple Hospitalizations for Symptomatic COVID-19
SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation
Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19.
Comment on: Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19.
Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia.
A Child with Acute Lymphoblastic Leukemia in Institutional Isolation during the COVID Pandemic: A Multifaceted Responsibility.
SARS-CoV-2 viral clearance during bone marrow aplasia after allogeneic hematopoietic stem cell transplantation - a case report.
SARS-CoV-2 Infection During Induction Chemotherapy in a Child With High-risk T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Clinical characteristics and outcome of SARS-CoV-2 infection in Italian pediatric oncology patients: a study from the Infectious Diseases Working Group of the AIEOP.
SARS-CoV-2 infection in a neutropenic pediatric patient with leukemia: Addressing the need for universal guidelines for treatment of SARS-CoV-2-positive, immunocompromised patients.
COVID-19 and childhood acute lymphoblastic leukemia
COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE)
Clinical Strategies for Treating Pediatric Cancer During the Outbreak of 2019 Novel Coronavirus Infection
Challenges posed by COVID-19 to children with cancer